Corient Capital Partners, LLC Medtronic PLC Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Corient Capital Partners, LLC holds 101,932 shares of MDT stock, worth $8.97 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

101,932

Previous 101,932 -0.0%

Holding current value

$8.97 Million

Previous $9.15 Million -0.0%

% of portfolio

0.68%

Previous 0.69%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$87.4 - $113.09 $464,443 - $600,960	-5,314 Reduced 4.95%	101,932 $9.15 Million
Q1 2022 May 16, 2022	BUY	$100.58 - $112.38 $58,235 - $65,068	579 Added 0.54%	107,246 $11.9 Million
Q4 2021 Feb 11, 2022	BUY	$99.53 - $127.75 $841,028 - $1.08 Million	8,450 Added 8.6%	106,667 $11 Million
Q3 2021 Nov 16, 2021	BUY	$122.75 - $135.17 $1.43 Million - $1.57 Million	11,609 Added 13.4%	98,217 $12.3 Million
Q2 2021 Aug 16, 2021	BUY	$118.19 - $131.5 $1.33 Million - $1.48 Million	11,254 Added 14.93%	86,608 $10.8 Million
Q1 2021 May 17, 2021	BUY	$111.18 - $119.74 $172,662 - $185,956	1,553 Added 2.1%	75,354 $8.9 Million
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $128,126 - $149,236	1,274 Added 1.76%	73,801 $8.65 Million
Q3 2020 Nov 16, 2020	BUY	$90.13 - $108.78 $118,611 - $143,154	1,316 Added 1.85%	72,527 $7.54 Million
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $1.35 Million - $1.65 Million	15,996 Added 28.97%	71,211 $6.53 Million
Q1 2020 May 06, 2020	SELL	$72.92 - $121.3 $223,135 - $371,178	-3,060 Reduced 5.25%	55,215 $4.98 Million
Q4 2019 Feb 04, 2020	BUY	$104.49 - $114.54 $153,077 - $167,801	1,465 Added 2.58%	58,275 $6.61 Million
Q3 2019 Nov 06, 2019	BUY	$98.02 - $111.18 $181,925 - $206,350	1,856 Added 3.38%	56,810 $6.17 Million
Q2 2019 Aug 08, 2019	BUY	$84.15 - $99.38 $40,055 - $47,304	476 Added 0.87%	54,954 $5.35 Million
Q1 2019 May 10, 2019	SELL	$82.45 - $93.79 $324,688 - $369,345	-3,938 Reduced 6.74%	54,478 $4.96 Million
Q4 2018 Feb 07, 2019	BUY	$85.8 - $99.49 $2.28 Million - $2.64 Million	26,518 Added 83.13%	58,416 $5.31 Million
Q2 2018 Oct 02, 2018	BUY	$77.48 - $87.83 $742,258 - $841,411	9,580 Added 42.92%	31,898 $2.73 Million
Q1 2018 May 14, 2018	BUY	$76.55 - $87.26 $275,886 - $314,485	3,604 Added 19.26%	22,318 $1.79 Million
Q4 2017 Feb 13, 2018	BUY	$76.93 - $83.5 $129,627 - $140,697	1,685 Added 9.89%	18,714 $1.51 Million
Q3 2017 Nov 14, 2017	SELL	$77.71 - $84.6 $388 - $423	-5 Reduced 0.03%	17,029 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,120 Added 7.04%	17,034 $1.51 Million
Q1 2017 Aug 17, 2017	BUY	N/A	10,169 Added 177.01%	15,914 $1.28 Million
Q1 2017 Aug 14, 2017	BUY	N/A	5,745	5,745 $573,000

Others Institutions Holding MDT

# of Institutions

2,255

Shares Held

1.04B

Call Options Held

7.13M

Put Options Held

4.44M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Medtronic PLC Transaction History